Meiwu Tech Reports on Skincare Business Development

TL;DR

Meiwu Tech is expanding into functional skincare via its subsidiary Vande Technology.

AI Summary

Meiwu Technology Co Ltd, formerly Wunong Net Technology Co Ltd, filed a Form 6-K on December 31, 2024, reporting on the development of its functional skincare business. The filing mentions Shenzhen Vande Technology Co., Limited, a Hong Kong-based entity, in relation to this business development.

Why It Matters

This filing provides an update on Meiwu Technology's strategic business initiatives, specifically its expansion into the functional skincare market, which could impact future revenue streams.

Risk Assessment

Risk Level: low — The filing is a routine update on business development and does not contain significant financial or operational risks.

Key Players & Entities

• Meiwu Technology Co Ltd (company) — Registrant
• Wunong Net Technology Co Ltd (company) — Former company name
• Shenzhen Vande Technology Co., Limited (company) — Entity involved in functional skincare business
• September 3, 2024 (date) — Date related to Vande Technology's organization
• December 31, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $10 — all the equity interests of Magnum for $10. On 2024, the transaction contemplated

Filing Documents

• form6-k.htm (6-K) — 36KB
• ex10-1.htm (EX-10.1) — 52KB
• ex10-2.htm (EX-10.2) — 85KB
• ex10-3.htm (EX-10.3) — 84KB
• form6-k_001.jpg (GRAPHIC) — 56KB
• form6-k_002.jpg (GRAPHIC) — 43KB
• 0001493152-24-052724.txt ( ) — 394KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-39803 Meiwu Technology Company Limited (Translation of registrant’s name into English) 1602, Building C, Shenye Century Industry No. 743 Zhoushi Road, Bao’an District Shenzhen, People’s Republic of China Telephone: +86-755-85250400 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Development of the Functional Skincare Business On September 3, 2024, Shenzhen Vande Technology Co., Limited (“ Vande ”) a limited company organized under the laws of Hong Kong and a wholly owned subsidiary of Meiwu Technology Company Limited, a British Virgin Islands company (the “ Company ”), incorporated a limited liability company under the laws of People’s Republic of China with the name of Xiamen Chunshang Health Technology Co., Ltd. (the “ Chunshang Xiamen ”). As previously disclosed, the Company was planning to implement a strategic transition in its business to expand into the sales of functional skincare products. In addition to the preliminary steps it took to acquire certain trademarks for certain skincare products and enter into letters of intent with distributors, the Company, through Chunshang Xiamen, has entered into sales agreement with a client in the last quarter of 2024 to sell certain functional skincare products manufactured by the third-party manufacturer engaged by Chunshang Xiamen for RMB 250,000. Entry into Material Agreements On December 10, 2024, Guogangtong Trading (Shenzhen) Co., Ltd. (“ WFOE ”), the wholly owned subsidiary of Vande entered into an agreement (the “ Termination Agreement ”) with Meiwu Zhishi Technology (Shenzhen) Co., Ltd. (“ Meiwu Zhishi ” or “ VIE ”), VIE’s shareholders to terminate of a series of contractual arrangements (“ VIE Agreements ”) by and among the VIE, the WFOE, and shareholders of the VIE. A copy of the English translation of the Termination Agreement is attached hereto as Exhibit 10.1. The foregoing description of the Termination Agreement is a summary of the material terms of such agreement, and does not purport to be complete and is qualified in its entirety by reference to the Termination Agreement. On December 24, 2024, the Company, Magnum International Holdings Limited, a British Virgin Islands company with limited liabilities and a wholly owned subsidiary of the Company (“ Magnum ”) and an individual that is not affiliated with the Company or any of its directors or officers (the “ Purchaser ”) entered into a certain share transfer agreement (“ Magnum Disposition Agreement ”). Pursuant to the Magnum Disposition Agreement, the Purchaser agreed to purchase all the equity interests of Magnum for $10. On 2024, the transaction contemplated therein (the “ Magnum Disposition ”) was closed, and the Purchaser became the sole shareholder of Magnum and as a result, assume all assets and liabilities of Magnum and subsidiaries owned or controlled by Magnum. A copy of the Magnum Disposition Agreement is attached hereto as Exhibit 10.2. The foregoing description of the Magnum Disposition Agreement is a summary of the material terms of such agreement, and does not purport to be complete and is qualified in its entirety by reference to the Magnum Disposition Agreement. On December 24, 2024, the Company, Xinfuxin International Holdings Limited, a British Virgin Islands company with limited liabilities and a wholly owned subsidiary of the Company (“ Xinfuxin ”) and the same Purchaser entered into a certain share transfer agreement (“ Xinfuxin Disposition Agreement ”, collectively with the Termination Agreement and Magnum Disposition Agreement, the “ Agreements ”). Pursuant to the Xinfuxin Disposition Agreement, the Purchaser agreed to purchase all the equity interests of Xinfuxin for $10. On December 31, 2024, the transaction contemplated therein (the “ Xinfuxin Disposition ”) was closed, and the Purchaser became the sole shareholder of Xinfuxin and as a result, assume all assets and liabilities of Xinfuxin and subsidiaries owned or controlled by Xinfuxin. A copy of the Xinfuxin Disposition Agreement is attached hereto as Exhibit 10.3. The foregoing description of the Xinfuxin Disposition Agreement is a summary of the material terms of such agreement, and does not purport to be complete and is qualified in its entirety by reference to the Xinfuxin Disposition Agreement. Below is a diagram that illustrates the Company’s corporate structure immediately pr

View Full Filing

View this 6-K filing on SEC EDGAR